Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06532656
What this trial is testing

Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 75
Not applicableStudy completedNCT00400322
What this trial is testing

Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

Who this might be right for
Glioblastoma MultiformeCytomegalovirus Infection
Karolinska Institutet 42
Not applicableUnknownNCT03895294
What this trial is testing

Effect of Strategies for the Treatment of Chronic Hepatitis C in Colombia

Who this might be right for
Hepatitis C
Universidad de Antioquia 124
Testing effectiveness (Phase 2)WithdrawnNCT00000697
What this trial is testing

Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Post-approval studies (Phase 4)UnknownNCT02532413
What this trial is testing

Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 180
Testing effectiveness (Phase 2)Study completedNCT02405013
What this trial is testing

Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa

Who this might be right for
Hepatitis CHIV Infection
ANRS, Emerging Infectious Diseases 120
Testing effectiveness (Phase 2)Study completedNCT00514449
What this trial is testing

Systematic Evaluation of Antiviral Medication in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Konasale Prasad 31
Testing effectiveness (Phase 2)Study completedNCT00211848
What this trial is testing

Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers

Who this might be right for
Hepatitis C
Icahn School of Medicine at Mount Sinai 207
Early research (Phase 1)Study completedNCT00793793
What this trial is testing

Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 96
Not applicableStudy completedNCT02578693
What this trial is testing

Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 1,210
Testing effectiveness (Phase 2)Looking for participantsNCT07198139
What this trial is testing

Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus

Who this might be right for
Norovirus
Cocrystal Pharma, Inc. 40
Post-approval studies (Phase 4)UnknownNCT01765231
What this trial is testing

Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma

Who this might be right for
Hepatitis B
Peking University 190
Not applicableStudy completedNCT01581554
What this trial is testing

Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B e Antigen PositiveChronic Hepatitis B e Antigen Negative
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 15
Large-scale testing (Phase 3)UnknownNCT04320277
What this trial is testing

Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.

Who this might be right for
Pharmacological Action
Hospital of Prato 200
Testing effectiveness (Phase 2)Study completedNCT00000803
What this trial is testing

A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 471
Testing effectiveness (Phase 2)Study completedNCT00110305
What this trial is testing

TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines

Who this might be right for
Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 368
Testing effectiveness (Phase 2)Study completedNCT02068222
What this trial is testing

Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection

Who this might be right for
Chronic Hepatitis CHepatitis C Virus
AbbVie 10
Not applicableEnded earlyNCT00037622
What this trial is testing

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.

Who this might be right for
Chronic Hepatitis B
Alexion Pharmaceuticals, Inc. 100
Post-approval studies (Phase 4)Ended earlyNCT03625687
What this trial is testing

Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant

Who this might be right for
Respiratory FailureHepatitis C
Massachusetts General Hospital 19
Large-scale testing (Phase 3)Ended earlyNCT00028067
What this trial is testing

A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor

Who this might be right for
HIV Infections
Bristol-Myers Squibb 500
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation